- $67.97m
- $60.15m
- $60.88m
- 15
- 29
- 57
- 25
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | 28.28 | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 4.44 | ||
Price to Tang. Book | 6.45 | ||
Price to Free Cashflow | n/a | ||
Price to Sales | 1.12 | ||
EV to EBITDA | n/a |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | -243.67% | ||
Return on Equity | -209.93% | ||
Operating Margin | -71.71% |
Financial Summary
Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | $m | 54.41 | 51.06 | 121.54 | 137.14 | 60.88 | 95.25 | 167.12 | 18.79% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
SurgePays, Inc. is a financial technology and telecommunications company. The Company operates through two primary business segments: Mobile Virtual Network Operator (MVNO) Telecommunications and Comprehensive Platform Services. The MVNO Telecommunications segment is engaged in providing reliable, affordable prepaid wireless services. The MVNO segment is also engaged in offering subsidized and prepaid options to meet diverse financial needs. The Comprehensive Platform Services segment is engaged in offering point-of-sale (POS) transaction and marketing technology. Through SurgePays Prepaid Wireless Top-ups and ClearLine, it delivers transaction and marketing solutions that aim to transform convenience stores. The Prepaid Wireless Top-Ups platform empowers convenience store clerks to handle top-ups for all major wireless brands. In addition, it supports debit and gift card activations. ClearLine technology transforms POS terminals and customer-facing screens into engagement tools.
Directors
- Kevin Cox CHM (42)
- Anthony Nuzzo PRE (60)
- Anthony George Evers CFO (56)
- David Ansani CAD (54)
- Carter Matzinger OTH (45)
- Jay Jones DRC
- David May DRC
- David Keys IND (58)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- August 22nd, 2006
- Public Since
- July 24th, 2007
- No. of Shareholders
- 7,277
- No. of Employees
- 130
- Sector
- Telecommunications Services
- Industry
- Telecoms
- Exchange
NASDAQ Capital Market
- Shares in Issue
- 20,411,549

- Address
- 3124 Brother Blvd Ste 104, BARTLETT, 38133
- Web
- https://surgepays.com/
- Phone
- +1 9013029587
- Auditors
- Rodefer, Moss & Co., PLLC
Upcoming Events for SURG
Q1 2025 Surgepays Inc Earnings Release
Q2 2025 Surgepays Inc Earnings Release
Similar to SURG
Anterix
NASDAQ Capital Market
Center Mobile Co
NASDAQ Capital Market
iOThree
NASDAQ Capital Market
Nextplat
NASDAQ Capital Market
Sify Technologies
NASDAQ Capital Market
FAQ
As of Today at 23:30 UTC, shares in Surgepays are trading at $3.33. This share price information is delayed by 15 minutes.
Shares in Surgepays last closed at $3.33 and the price had moved by -0.89% over the past 365 days. In terms of relative price strength the Surgepays share price has underperformed the S&P500 Index by -8.52% over the past year.
The overall consensus recommendation for Surgepays is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreSurgepays does not currently pay a dividend.
Surgepays does not currently pay a dividend.
Surgepays does not currently pay a dividend.
To buy shares in Surgepays you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $3.33, shares in Surgepays had a market capitalisation of $67.97m.
Here are the trading details for Surgepays:
- Country of listing: United States
- Exchange: NAQ
- Ticker Symbol: SURG
Based on an overall assessment of its quality, value and momentum Surgepays is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Surgepays is $6.75. That is 102.7% above the last closing price of $3.33.
Analysts covering Surgepays currently have a consensus Earnings Per Share (EPS) forecast of -$0.07 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Surgepays. Over the past six months, its share price has outperformed the S&P500 Index by +101.71%.
As of the last closing price of $3.33, shares in Surgepays were trading +78.14% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Surgepays PE ratio based on its reported earnings over the past 12 months is 28.28. The shares last closed at $3.33.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Surgepays' management team is headed by:
- Kevin Cox - CHM
- Anthony Nuzzo - PRE
- Anthony George Evers - CFO
- David Ansani - CAD
- Carter Matzinger - OTH
- Jay Jones - DRC
- David May - DRC
- David Keys - IND